Amber Salzman

Amber Salzman

Chief Executive Officer at
Epicrispr Biotechnologies, Inc.
64 year
Health Technology
Consumer Services
Commercial Services

Profile

Amber Salzman is the founder of Annapurna Therapeutics SAS, which was founded in 2012.
She held the title of President & Chief Executive Officer from 2012 to 2016.
Currently, she is the President, Chief Executive Officer & Director at Ohana Biosciences, Inc., the Chief Executive Officer at Epicrispr Biotechnologies, Inc., the Director at Drexel University School of Public Health, the Director at Ald Connect, Inc., a Non-Executive Director at AviadoBio Ltd., and a Trustee at Lankenau Institute for Medical Research.
She is also the President of The Stop ALD Foundation since 2001.
In her former positions, she was the President & Chief Executive Officer of CardioKine, Inc. from 2009 to 2011, the President, Chief Executive Officer & Director of Adverum Biotechnologies, Inc. from 2016 to 2018, and a Director at Akcea Therapeutics, Inc. in 2020.
She was also a Member-Research & Development Executive Team at GSK Plc.
Dr. Salzman holds a doctorate degree from Bryn Mawr College and an undergraduate degree from Temple University (Pennsylvania).

Amber Salzman active positions

CompaniesPositionStart
President 28/02/2001
Director/Board Member -
Director/Board Member -
Director/Board Member -
Director/Board Member -
Chief Executive Officer -

Former positions of Amber Salzman

CompaniesPositionEnd
AKCEA THERAPEUTICS, INC. Director/Board Member 11/10/2020
ADVERUM BIOTECHNOLOGIES, INC. Chief Executive Officer 02/05/2018
Chief Executive Officer 31/12/2015
░░░░░░░░░░░ ░░░░ ░░░░░ ░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░
░░░░░ ░░░░░░░░░░░░ ░░░░ ░░░░░ ░░░░░░░░░ ░░░░░░░ -
See the detail of Amber Salzman's experience

Training of Amber Salzman

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

33

1st degree connections

14

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies14

Health Technology

Health Technology

Consumer Services

Consumer Services

Health Technology

Health Technology

Health Technology

Consumer Services

Health Technology

Commercial Services

Health Services

Commercial Services

Health Technology

Commercial Services

-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!